Exercise-induced Bronchospasm
7
0
0
3
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 30/100
0.0%
0 terminated out of 7 trials
100.0%
+13.5% vs benchmark
43%
3 trials in Phase 3/4
0%
0 of 3 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 3 completed trials
Clinical Trials (7)
Prevalence of EILO Among Children With Asthma
Comparison of Two Bronchodilator Inhalers in Adolescents and Adults With Exercise-Induced Asthma
Mechanisms of Exercise-induced Bronchospasm
Vitamin C & Exercise Induced Bronchoconstriction (EIB)
Effects of Montelukast on Occult Exercise-Induced Bronchospasm in Athletes
Bronchoprotective Effect of Arformoterol in Children With Exercise-Induced Bronchospasm (EIB)
Efficacy Study of Single-Dose Levalbuterol Tartrate HFA MDI Vs Placebo in Subjects 18 Years and Older With EIB